Drugs / Pentavalent
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05155579 | May 2022 → May 2025 | malaria | University of Oxford | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pentavalent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05155579 ↗ |
| Modality | Vaccine | “Licensed vaccine - Pentavalent (diphtheria, tetanus, pertussis, hepatitis B and Hib)” NCT05155579 ↗ |